Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hims & Hers Health Inc.

25.99
-2.0000-7.15%
Post-market: 25.45-0.5400-2.08%19:59 EDT
Volume:27.69M
Turnover:712.35M
Market Cap:5.77B
PE:48.83
High:27.09
Open:26.30
Low:23.97
Close:27.99
Loading ...

Stocks to Watch: Eli Lilly, Novo Nordisk, Hims & Hers, Maxeon Solar Technologies

Dow Jones
·
1 hour ago

Hims & Hers Health (NYSE:HIMS) Rises 5% Over Last Quarter Following Strong 2024 Earnings

Simply Wall St.
·
5 hours ago

Analysts Stay Cautious on HIMS Stock amid Core Business Uncertainty

TipRanks
·
03 Apr

‘Hold the Phone,’ Says Morgan Stanley on Hims & Hers Health Stock (HIMS)

TIPRANKS
·
03 Apr

3 Stocks to Buy for "Liberation" From Trump Tariffs & Recession Woes

Zacks
·
03 Apr

Hims & Hers Betting on FDA Loophole to Keep Selling Compounded Medications -- Market Talk

Dow Jones
·
03 Apr

Hims & Hers Liraglutide Launch Could Drive More Growth Than Zepbound -- Market Talk

Dow Jones
·
03 Apr

Hims & Hers Zepbound Offering Won't Bring Needed Sales Boom, Analysts Say -- Analysis

Dow Jones
·
03 Apr

Hims & Hers Health's Launch of Liraglutide on Telehealth Platform Seen as 'Incrementally Positive,' Says Truist Securities

MT Newswires Live
·
02 Apr

Hims & Hers falls -6.1%

TIPRANKS
·
02 Apr

Truist Financial Sticks to Their Hold Rating for Hims & Hers Health (HIMS)

TIPRANKS
·
02 Apr

Eli Lilly Says It Has No Affiliation With Hims & Hers Regarding Zepbound

MT Newswires Live
·
02 Apr

Hims & Hers to Sell Lilly's Weight-Loss Drug on Its Telehealth Platform

Reuters
·
02 Apr

BRIEF-Eli Lilly Has No Affiliation With Hims & Hers

Reuters
·
02 Apr

Eli Lilly: Zepbound (Tirzepatide) Can Be Prescribed by Any Licensed Healthcare Professional - Website

THOMSON REUTERS
·
02 Apr

‘Don’t Fall for the Hype,’ Says Top Analyst about HIMS’ Decision to Sell Zepbound

TIPRANKS
·
02 Apr

Hims & Hers Expands Weight Loss Offering, Adds Lilly's Zepbound to Platform

Dow Jones
·
02 Apr

BUZZ-Hims & Hers rises after plan to sell Eli Lilly's weight loss drug on its platform

Reuters
·
02 Apr

Hims & Hers adding access to generic liraglutide, branded tirzepatide

TIPRANKS
·
02 Apr

BRIEF-Hims & Hers Health Says Adding Access To Generic Liraglutide, Branded Tirzepatide Via Platform

Reuters
·
02 Apr